KNW stock touches 52-week low at $0.55 amid steep annual decline

Published 03/04/2025, 15:52
KNW stock touches 52-week low at $0.55 amid steep annual decline

In a challenging year for Know Labs, the company’s stock has hit a 52-week low, trading at $0.55, with InvestingPro analysis showing concerning financial health metrics, including a weak current ratio of 0.2 and significant debt burden. This price point marks a significant downturn for the tech firm, which has seen its shares plummet by an alarming 97.83% over the past year. Investors have been wary as the company grapples with market pressures and internal challenges, reflected in its negative EBITDA of -$14.42M and concerning return on assets of -542.65%. The 52-week low serves as a stark indicator of the hurdles Know Labs faces as it strives to regain its footing in a competitive industry. According to InvestingPro, which offers 16 additional investment insights for this stock, technical indicators suggest the stock is currently in oversold territory.

In other recent news, Know Labs Inc. reported a net loss of $4.67 million for the first quarter of fiscal year 2025, an increase from the $3.45 million loss in the same period the previous year. Despite this, the company managed to reduce its cash burn rate by 44% to $1.89 million. Know Labs also launched a new licensing program for its Radio Frequency Dielectric Spectroscopy (RFDS) sensor platform, aiming to expand its technology through partnerships and licensing. The company’s cash and cash equivalents decreased to $1.03 million from $3.11 million in September. Research and development expenses saw a significant reduction, decreasing by 46% year-over-year to $802,000. Selling, general, and administrative expenses were slightly reduced by 2% from the previous year, totaling $1.97 million. Know Labs is actively pursuing FDA approval for its Know You product and plans to raise additional funds through equity issuance, preferred stock, and convertible debentures. The company faces challenges such as limited cash reserves and a trading suspension by the NYSE, which may impact its operations beyond April 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.